NVS

Contract Research and Manufacturing Services (CRAMS) Business Report 2025: Market to Reach $211.4 Billion by 2030, Fueled by Growing Demand for Biologics and Biosimilars

05/08 10:55 am

Generic Oncology Drugs Market Size Estimated to Reach USD 30,998 Mn by 2034, Rising Global Cancer Cases Increase Demand for Affordable Treatments

05/07 11:00 am

Liver Cancer Treatment Market is expected to generate a revenue of USD 8.88 Billion by 2031, Globally, at 13.45% CAGR: Verified Market Research®

05/02 10:00 am

Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight

04/30 01:00 pm

Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million

04/30 11:22 am

Novartis Q1 Earnings Beat Street View, CEO 'Confident' In Delivering Upgraded Guidance

04/29 12:39 pm

These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?

04/26 10:15 am

Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs

04/22 03:21 pm

Gastric Neuroendocrine Tumors Market Report 2025 | Advancements in Diagnostics Propel Early Detection of gNETs

04/21 06:49 am

Huntington's Disease Treatment Market to Hit $2.03 Billion by 2033, Driven by Cutting-Edge Therapies

04/18 04:28 am

Atopic Dermatitis Drugs Market Forecast 2025-2034 | Rising Drug Approvals and Clinical Trial Successes Propel Revenue Growth, Making Atopic Dermatitis a High-Growth Market

04/18 04:26 am

Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties

04/11 09:36 am

Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight

04/10 01:00 pm

Biopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline

04/10 05:59 am

Ophthalmology Market Report 2025 | Industry to Reach US$93.7 Billion by 2030 | Emerging Research Activities of Ophthalmology Treatments and Availability of Grants Present Business Opportunities

04/08 04:52 am

Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)

04/02 08:13 pm

Why Pfizer Is My Largest Healthcare Position

03/27 06:45 am

Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

03/21 12:31 pm

FDA Approves Expanded Use Of Novartis Rare Disease Drug As Only Treatment For Rare Type Of Kidney Disease

03/21 11:36 am

Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy

03/19 01:09 pm

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - Report by Transparency Market Research, Inc.

03/13 06:00 pm

Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - Global Forecast to 2030

03/12 11:50 am

Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins

03/12 02:28 am

Cancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection

03/06 05:55 am

CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain

03/05 02:00 pm

3 Dividend Stocks That Are No-Brainer Buys Right Now

03/01 06:51 am

Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)

02/28 10:00 am

TALTZ’s Rapid Market Ascent Reflects its Unparalleled Ability to Transform the Treatment Landscape for Autoimmune Diseases | DelveInsight

02/24 02:00 pm

NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects

02/24 01:39 pm

Questex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education

02/24 11:00 am

Evolving Landscape of Obesity: Key Market Insights of Latest Published Different Types of Obesity | DelveInsight

02/21 02:00 pm

Hyperlipidemia Drugs Market Size to Promote USD 31.49 Bn by 2034

02/21 11:00 am

BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment

02/20 02:00 pm

Polycythemia Vera Market Insight, Epidemiology and Market Forecast, 2034: JAKAFI & BESREMi Lead Polycythemia Vera Market, But New Therapies Poised to Disrupt by 2034

02/17 01:57 pm

Novartis To Beef Up Heart Disease Offering With $3 Billion Blackstone-Backed Anthos Therapeutics Deal

02/11 12:02 pm

Neuroregeneration Therapy Market to Surpass USD 64.8 Billion by 2034, Driven by Advancements in Regenerative Medicine and Rising Neurological Disorders | Transparency Market Research

02/11 04:48 am

Paresthesia Treatment Market Outlook: USD 8.0 Billion by 2034, Growing with an Aging Population and Rising Healthcare Expenditures | Analysis by TMR

02/07 12:39 pm

Aplastic Anemia Global Clinical Trials Review 2024 | Now Available

02/04 12:00 pm

2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond

02/03 09:32 am

Recombinant Chemicals Market to Reach US$ 6.7 Bn by 2034, Driven by Rising Demand for Protein-Based Vaccines & Genetic Disorder Treatments – TMR Analysis

01/31 10:00 am

Novartis Q4: Earnings Beat Estimates, CEO Dismisses Entresto Patent Expiration Worries

01/31 07:26 am

BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight

01/29 02:00 pm

Biological Drugs Strategic Research Report 2024-2030, Profiles of 45+ Players Including Abbott Laboratories, Amgen, Baxter, Biogen, BMS, Eli Lilly and Co, GSK, Merck, Novartis, and Pfizer

01/27 11:49 am

Pain Management Therapeutics Market Is Expected To Reach Revenue Of USD 120.7 Bn By 2033, At 3.9% CAGR: Dimension Market Research.

01/20 10:55 am

7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - Synergistic Rise of Pumps, CGMs, and Ultra-rapid-acting Insulins in T1D Management

01/17 05:53 am

Global Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica

01/17 04:30 am

Yseop Kicks Off 2025 by Strengthening Its Leadership in Generative AI for Life Sciences

01/15 10:00 am

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight

01/14 02:00 pm

Ophthalmic Drugs Global Market Report 2025: Innovations in Retinal Disorders, Glaucoma Drive Global Ophthalmic Medicines Surge

01/13 05:46 am

Novartis Entresto® US patent upheld by US Court of Appeals

01/13 02:15 am